ERBB2 and breast carcinoma: Based on the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2), breast cancer can be divided into at least three subtypes: luminal, HER2-enriched, and triple-negative, which exhibit different histopathological features and treatment sensitivities2.